Tag: Aptar Pharma
Nanopharm announces expansion to enable full services solutions
Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products (OINDPs), has announced expansion...
Aptar Pharma partners with Stallergenes Greer
Aptar Pharma, a global leader in drug delivery systems, services, and active material science solutions, announced an exclusive partnership with Stallergenes Greer, a global...
Aptar’s nasal pump system receives approval for dry eye disease
AptarGroup, a global leader in drug delivery, consumer product dispensing, and active material science solutions, announced that its patented Cartridge Pump System (CPS), designed...
Aptar receives award for expanding production capacity for its Activ‐Film technology
Aptar CSP’s Activ‐Film technology is seamlessly integrated into diagnostic dipsticks and lateral flow cassettes to protect diagnostic tests from moisture or other environmental degradants...
BD launches plunger stopper in partnership with Aptar Pharma
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of the BD SCF PremiumCoat plunger stopper in partnership with...
Aptar Pharma — Injectables solutions showcase at 2021 PDA PFS Online...
Aptar originally developed spray valves and pumps for consumer and household products. Later, the company began producing nasal administration and pulmonary drug delivery devices such as nasal...
Next Breath hosts a webinar on Extractables & Leachables for injectable...
Next Breath is a specialty company of Aptar Pharma and a full-service cGMP compliant laboratory located in Baltimore, Maryland. It specializes in analytical testing...
Aptar acquires a majority stake in Voluntis
Aptar, a global leader in drug delivery, consumer product dispensing, and active material science solutions, announced that following the signature of a share purchase...
Aptar Pharma announces its partnership with Pharmaxis
Aptar Pharma, a global leader in drug delivery systems, services, and active material science solutions, announced that they have agreed with Pharmaxis, a clinical-stage...
Aptar to acquire Weihai Hengyu medical products for injectable drug delivery
Aptar announced that it has agreed to acquire 80% of the equity interests of Weihai Hengyu Medical Products, a leading Chinese manufacturer of elastomeric...